Multiresistant-MRSA tricuspid valve infective endocarditis with ancient osteomyelitis locus

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Chesi, Giuseppe ^a   Colli, Andrea ^b   Mestres, Carlos A ^c   Gambarati, Gianpaolo ^a   Boni, Fabrizio ^a   Gherli, Tiziano ^b  

^a C Magati Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ABOVE KNEE AMPUTATION; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATION; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; GENE LOCUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION CONTROL; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; REMISSION; TRAFFIC ACCIDENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HEART VALVE DISEASES; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBSTANCE-RELATED DISORDERS; TRICUSPID VALVE; VIRGINIAMYCIN;

EID: 33747495217     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-124     Document Type: Article

References (9)

1. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F: Changing Profile of Infective Endocarditis. Result of a year survey in France. JAMA 2002, 288:75-81.
2. Moss R, Munt B: Injection drug use and right side endocarditis. Heart 2003, 89:577-581.
3. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S: Staphylococcus Aureus bacteremia and Endocarditis: the Grady Memorial Hospital experience with meticillin-sensitive S aureus and meticillin-resistant S aureus bacteremia. Am Heart J 2004, 147:536-539.
4. Eliopoulos GM: Current and new antimicrobial agents. Am Heart J 2004, 147:587-592.
5. Woods CW, Cheng AC, Fowler VG Jr, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P. Wilson KH: Endocarditis caused by Staphylococcus Aureus with reduced susceptibility to Vancomycin. Clini Infect Dis 2004, 38:1088-1091.
6. Ruiz EM, Guerrero IC, Tuazon CU: Endocarditis caused by Methicillin resistant Staphylococcus Aureus: treatment failure with linezolid. Clin Infect Dis 2002, 35: 1018-1020.
7. Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R. Intrapulmonary penetration of linezolid. J Antimicrob Chemother 2003, 51:1431-1434.
8. Drew RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH: Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin/dalfopristin in patients intolerant of or failing prior therapy. J Antimicrob Chermother 2000, 16:775-784.
9. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA O'Gara PT, O'Rourke RA, Rahimtoola SH, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Gibbons RJ, Russell RO, Ryan TJ, Smith SC Jr ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998, 7(6):672-707.